Hou Jinfeng, Feng Wei, Zhao Hanbin, Cui Mengying, Wang Yi, Guo Zhenhua, Liu Wei
National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, Chongqing Key Laboratory of Pediatrics, Department of General Surgery & Neonatal Surgery Children'S Hospital of Chongqing Medical University, Mailing Address:20 Jinyu Avenue, Liangjiang New District, Chongqing, 401122, China.
Pediatr Surg Int. 2025 Feb 27;41(1):87. doi: 10.1007/s00383-025-05988-x.
The treatment of Hirschsprung's disease (HD) in infants with the robotic-assisted Swenson procedure has been rarely reported. In this investigation, we aimed to explore the safety and the efficacy of robotic-assisted Swenson procedure for the HD in infants.
From November 2022 to July 2023, 17 cases of HD were treated with the Da Vinci robotic Xi surgical system using a three-port approach. Preoperative, intraoperative, and postoperative data were collected and compared with 43 cases of HD treated with laparoscopy by the same lead surgeon.
The robotic-assisted surgery (RAS) group included 17 infants, and the laparoscopic surgery (LS) group included 43 infants, with a median surgical age of 35 days for both groups. There were no statistically significant differences between the two groups in terms of surgical age, gender, preoperative weight, preoperative hospital stay, preoperative enema time, and incidence of preoperative enterocolitis. Estimated intraoperative blood loss and transfusion rate in the RAS group were both lower than in the LS group, with statistically significant differences. There were no statistically significant differences in early and midterm postoperative complications (anastomotic leaks, anastomotic strictures, enterocolitis, etc.) between the two groups.
This study demonstrates the efficacy and the safety of robotic-assisted Swenson procedure in infants.
机器人辅助Swenson手术治疗婴儿先天性巨结肠（HD）的报道较少。在本研究中，我们旨在探讨机器人辅助Swenson手术治疗婴儿HD的安全性和有效性。
2022年11月至2023年7月，17例HD患儿采用达芬奇Xi机器人手术系统经三孔法进行治疗。收集术前、术中和术后数据，并与同一位主刀医生采用腹腔镜治疗的43例HD患儿进行比较。
机器人辅助手术（RAS）组有17例婴儿，腹腔镜手术（LS）组有43例婴儿，两组的中位手术年龄均为35天。两组在手术年龄、性别、术前体重、术前住院时间、术前灌肠时间和术前小肠结肠炎发生率方面无统计学显著差异。RAS组的估计术中失血量和输血率均低于LS组，差异有统计学意义。两组术后早期和中期并发症（吻合口漏、吻合口狭窄、小肠结肠炎等）无统计学显著差异。
本研究证明了机器人辅助Swenson手术治疗婴儿HD的有效性和安全性。
